(Q41427637)

30 September 2017

title

T cells play an essential role in anti-F1 mediated rapid protection against bubonic plague (English)

1 reference

30 September 2017

4

Ayelet Zauberman

1 reference

30 September 2017

8

Avigdor Shafferman

1 reference

30 September 2017

1

Yinon Levy

1 reference

30 September 2017

5

Moshe Aftalion

1 reference

30 September 2017

6

Shirley Lazar

1 reference

30 September 2017

2

Yehuda Flashner

1 reference

30 September 2017

Avital Tidhar

3

1 reference

30 September 2017

David Gur

series ordinal

7

1 reference

30 September 2017

Emanuelle Mamroud

series ordinal

9

1 reference

30 September 2017

language of work or name

English

0 references

publication date

29 July 2011

1 reference

30 September 2017

1 reference

30 September 2017

volume

29

1 reference

30 September 2017

issue

40

1 reference

30 September 2017

page(s)

6866-6873

1 reference

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Current challenges in the development of vaccines for pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Role of fraction 1 antigen of Yersinia pestis in inhibition of phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Differential effects of deletions in lcrV on secretion of V antigen, regulation of the low-Ca2+ response, and virulence of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Endotoxin removal from protein solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Cell-mediated protection against pulmonary Yersinia pestis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Yersinia pestis (plague) vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Antigen-specific B-1a antibodies induced by Francisella tularensis LPS provide long-term protection against F. tularensis LVS challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Yersinia pestis IS1541 transposition provides for escape from plague immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Resistance of Yersinia pestis to complement-dependent killing is mediated by the Ail outer membrane protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

The Ability To Replicate in Macrophages Is Conserved between Yersinia pestis and Yersinia pseudotuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Suppression of cytokines in mice by protein A-V antigen fusion peptide and restoration of synthesis by active immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host gamma interferon and T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.07.059

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.07.059

1 reference

30 September 2017

1 reference